← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 12.4% to $176.2M, while Net income increased 168.2% to $78.3M.
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $176.2MOK
- Profitability — Net income $78.3MOK
- Cash generation — Free cash flow ($25.0M)Note
- Accounting — Formula distress score · no manipulation flag · earnings quality greyWatch
- Insiders — 0 buys; 12 sells in 365 daysNote
- Capital — share repurchases were $10.0MNote
Business
Cryoport, Inc.: Our solutions are purpose-built to support a broad range of global life sciences markets, including biopharmaceutical and pharmaceutical companies, the animal health markets, reproductive medicine, academic institutions, research, and government agencies.
Where the revenue comes from
Fiscal 2025, as Cryoport, Inc. reports it. History and quarterly detail are in the app.
- Life Sciences Services$102.1M
- Life Sciences Products$75.8M
Leadership changes
From Cryoport, Inc.'s own filings, the day they're filed.
- Edward Zecchini · President · departureeff. 2024-02-19
Latest filings
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-06-09
- 10-Q · Quarterly report2026-05-05
- 8-K · Company announcement2026-05-04
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Cryoport, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.